Phase I study of ontuxizumab, a humanized monoclonal antibody (mAb) recognizing endosialin in Japanese patients (pts) with hepatocellular carcinoma (HCC)
| العنوان: | Phase I study of ontuxizumab, a humanized monoclonal antibody (mAb) recognizing endosialin in Japanese patients (pts) with hepatocellular carcinoma (HCC) |
|---|---|
| المؤلفون: | Toshihiko Doi, Takuji Okusaka, Kenya Nakai, Takeshi Aramaki, Yoshitaka Inaba, Masafumi Ikeda |
| المصدر: | Journal of Clinical Oncology. 33:2521-2521 |
| بيانات النشر: | American Society of Clinical Oncology (ASCO), 2015. |
| سنة النشر: | 2015 |
| مصطلحات موضوعية: | chemistry.chemical_classification, Cancer Research, Stromal cell, business.industry, medicine.drug_class, Cell, medicine.disease, Monoclonal antibody, Endosialin, medicine.anatomical_structure, Oncology, chemistry, Hepatocellular carcinoma, medicine, Cancer research, Pericyte, Glycoprotein, business, Fibroblast |
| الوصف: | 2521 Background: Endosialin is a cell surface glycoprotein that is expressed on cells involved in the development of tumor vasculature, primarily pericyte and stromal fibroblast. Ontuxizumab is a h... |
| تدمد: | 1527-7755 0732-183X |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_________::b4942a51901602f67bb6de0681f58a09Test https://doi.org/10.1200/jco.2015.33.15_suppl.2521Test |
| رقم الانضمام: | edsair.doi...........b4942a51901602f67bb6de0681f58a09 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15277755 0732183X |
|---|